APA (7th ed.) Citation

A, H., X, X., AN, C., G, T., GA, B., L, G., . . . LS, M. (2024). Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results. Nature medicine, 30(4), 1210. https://doi.org/10.1038/s41591-024-02799-w

Chicago Style (17th ed.) Citation

A, Heczey, et al. "Author Correction: Anti-GD2 CAR-NKT Cells in Relapsed or Refractory Neuroblastoma: Updated Phase 1 Trial Interim Results." Nature Medicine 30, no. 4 (2024): 1210. https://doi.org/10.1038/s41591-024-02799-w.

MLA (9th ed.) Citation

A, Heczey, et al. "Author Correction: Anti-GD2 CAR-NKT Cells in Relapsed or Refractory Neuroblastoma: Updated Phase 1 Trial Interim Results." Nature Medicine, vol. 30, no. 4, 2024, p. 1210, https://doi.org/10.1038/s41591-024-02799-w.